Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
or bioinformaticians are actively sought in this cycle of recruitment. Candidates are expected to develop independent research in a bio-medicine related fields, and to actively participate in the preclinical teaching
-
About the role: The Costa Laboratory (https://profiles.imperial.ac.uk/t.costa ), in the Department of Life Sciences (https://www.imperial.ac.uk/life-sciences ), Imperial College London, invites
-
, building upon our recent work published in Nature (https://www.nature.com/articles/s41586-025-09889-w ). Your Responsibilities As part of the role, you will be required to operate and maintain state
-
the causes of paediatric brain cancers and develop new therapies. With the recent establishment of an mRNA vaccine trial to treat paediatric brain cancer by our laboratory and colleagues we continue to
-
targets. What you would be doing: As the lead Research Associate for the microbial genome engineering aspect of the project, you will be responsible developing a high-throughput genome engineering platform
-
discovery, generating mechanistic data that directly informs the development of next‑generation medicines for neurological disorders Base Salary, Academic Level A $113,400 - $121,054 + 17% superannuation
-
discovery programs. Your key responsibilities will be to: design and execute wet‑lab experiments supporting neurological therapeutic development perform molecular biology and cloning, including construction
-
medical research institute focused on improving health by developing new diagnostics, better treatments and prevention strategies, specifically in the areas of Cancer, Infection and Inflammation, Brain and
-
analysis of genomic data at a transformative scale, and the development of cutting-edge tools and resources. THE OPPORTUNITY We are seeking a Data Product Owner or similar Data Professional to join the
-
translational therapeutic development. It is ideally suited to a scientist who is excited to turn large-scale genomic insights into new biological understanding and actionable therapeutic opportunities